Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8985051rdf:typepubmed:Citationlld:pubmed
pubmed-article:8985051lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C0027540lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C1609982lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C0024487lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C0260061lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C1522609lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C1554112lld:lifeskim
pubmed-article:8985051lifeskim:mentionsumls-concept:C0205421lld:lifeskim
pubmed-article:8985051pubmed:issue5lld:pubmed
pubmed-article:8985051pubmed:dateCreated1997-1-23lld:pubmed
pubmed-article:8985051pubmed:abstractTextDelayed cerebral necrosis (DN) is a significant risk for brain tumor patients treated with high-dose irradiation. Although differentiating DN from tumor progression is an important clinical question, the distinction cannot be made reliably by conventional imaging techniques. We undertook a pilot study to assess the ability of proton magnetic resonance spectroscopy (1H MRS) to differentiate prospectively between DN or recurrent/residual tumor in a series of children treated for primary brain tumors with high-dose irradiation.lld:pubmed
pubmed-article:8985051pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985051pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985051pubmed:languageenglld:pubmed
pubmed-article:8985051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985051pubmed:citationSubsetIMlld:pubmed
pubmed-article:8985051pubmed:statusMEDLINElld:pubmed
pubmed-article:8985051pubmed:monthDeclld:pubmed
pubmed-article:8985051pubmed:issn0360-3016lld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:JenkinsJ...lld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:SanfordR ARAlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:KingsleyP BPBlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:TaylorJ SJSlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:FOXJ PJPlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:ChenGGlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:HeidemanR LRLlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:LangstonJ WJWlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:HsuD WDWlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:OchsJ JJJlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:FoxI SISlld:pubmed
pubmed-article:8985051pubmed:authorpubmed-author:ReddickW EWElld:pubmed
pubmed-article:8985051pubmed:issnTypePrintlld:pubmed
pubmed-article:8985051pubmed:day1lld:pubmed
pubmed-article:8985051pubmed:volume36lld:pubmed
pubmed-article:8985051pubmed:ownerNLMlld:pubmed
pubmed-article:8985051pubmed:authorsCompleteYlld:pubmed
pubmed-article:8985051pubmed:pagination1251-61lld:pubmed
pubmed-article:8985051pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:meshHeadingpubmed-meshheading:8985051-...lld:pubmed
pubmed-article:8985051pubmed:year1996lld:pubmed
pubmed-article:8985051pubmed:articleTitleClinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.lld:pubmed
pubmed-article:8985051pubmed:affiliationDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.lld:pubmed
pubmed-article:8985051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8985051pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8985051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8985051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8985051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8985051lld:pubmed